International Textbook of Diabetes Mellitus Two Volume Set

 The International Textbook of Diabetes Mellitus has been a successful, well–respected medical textbook for almost 20 years, over 3 editions. Encyclopaedic and international in scope, the textbook covers all aspects of diabetes ensuring a truly multidisciplinary and global approach. Sections covered include epidemiology, diagnosis, pathogenesis, management and complications of diabetes and public health issues worldwide. It incorporates a vast amount of new data regarding the scientific understanding and clinical management of this disease, with each new edition always reflecting the substantial advances in the field. Whereas other diabetes textbooks are primarily clinical with less focus on the basic science behind diabetes, ITDM?s primary philosophy has always been to comprehensively cover the basic science of metabolism, linking this closely to the pathophysiology and clinical aspects of the disease.Edited by four world–famous diabetes specialists, the book is divided into 13 sections, each section edited by a section editor of major international prominence. As well as covering all aspects of diabetes, from epidemiology and pathophysiology to the management of the condition and the complications that arise, this fourth edition also includes two new sections on NAFLD, NASH and non–traditional associations with diabetes, and clinical trial evidence in diabetes. This fourth edition of an internationally recognised textbook will once again provide all those involved in diabetes research and development, as well as diabetes specialists with the most comprehensive scientific reference book on diabetes available. INDICE: ContributorsPreface.VOLUME 1.SECTION 1: EPIDEMIOLOGY.1 Classification of diabetes mellitus and other categories of glucose intolerance Dianna J. Magliano, Paul Zimmet & Jonathan Shaw.2 Epidemiology and risk factors for type 1 diabetes mellitusAndrea K. Steck & Marian J. Rewers.3 Epidemiology and geography of type 2 diabetes mellitusQing Qiao, Desmond E. Williams, Giuseppina Imperatore, K.M. Venkat Narayan & Jaakko Tuomilehto.SECTION 2: PHYSIOLOGY OF PANCREATIC FUNCTION.4 Development and maintenance of the islet cellTeresa L. Mastracci, Raghavendra G. Mirmira & Ryan M. Anderson.5 Pancreatic morphology in normal and diabetic statesRebecca L. Hull & Steven E. Kahn.6 Insulin gene expression and biosynthesisVincent Poitout, Roland Stein & Christopher J. Rhodes.7 –Cell biology of insulin secretionSusumu Seino, Tadao Shibasaki & Kohtaro Minami.8 Normal –cell function Andrea Natali, Stefano Del Prato & Andrea Mari.9 Neuropeptides and islet hormone secretionBo Ahrén.10 Biosynthesis, secretion, and action of glucagonPierre J. Lefèbvre.11 Incretin physiology in health and diseaseJuris J. Meier & Michael A. Nauck.SECTION 3: NORMAL PHYSIOLOGY OF INSULIN ACTION.12 Mechanisms of insulin signal transductionPaul R. Langlais, Lawrence J. Mandarino & W. Timothy Garvey.13 Regulation of glucose metabolism in liverShawn C. Burgess.14 Insulin actions in vivo: glucose metabolism Ele Ferrannini & Ralph A. DeFronzo.15 Measuring insulin action in vivoRichard N. Bergman & Marilyn Ader.16 Protein metabolism in health and diabetesElena Volpi & Jared Dickinson.17 Lipid and lipoprotein metabolism, hypolipidemic agents, and therapeutic goalsGissette Reyes–Soffer & Henry N. Ginsberg.18 Metabolomics: applications in type 2 diabetes mellitus and insulin resistanceSean H. Adams & John W. Newman.SECTION 4: NAFLD, NASH AND NON–TRADITIONAL ASSOCIATIONS WITH DIABETES.19 Pathogenesis of nonalcoholic fatty liver disease (NAFLD)Hannele Yki–Järvinen.20 Treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)Fernando Bril, Kwame Ntim, Romina Lomonaco & Kenneth Cusi.21 Type 2 diabetes and cancerEmily Jane Gallagher, Ruslan Novosyadlyy & Derek LeRoith.22 Diabetes and sleep apnea Abd A. Tahrani.SECTION 5: PATHOGENESIS.23 The insulin resistance syndrome Naveed Sattar, Paul Welsh & David Preiss.24 –Cell mass and function in human type 2 diabetesPiero Marchetti & Ele Ferrannini.25 Pathogenesis of type 2 diabetes mellitusRalph A. DeFronzo.26 The genetics of type 2 diabetesEmma Ahlqvist & Leif Groop.27 Glucose toxicity Hannele Yki–Järvinen & Donald A. McClain.28 Monogenic disorders of the cellAli J. Chakera & Andrew T. Hattersley.29 Immunopathogenesis of type 1 diabetes in Western societyAlberto Pugliese.30 Molecular genetics of type 1 diabetesM. Ann Kelly, Simon D. Rees, Anthony H. Barnett & Stephen C. Bain.SECTION 6: OBESITY.31 The relationship between obesity and type 2 diabetes the role of gut factorsDaniel S. Hsia & William T. Cefalu.32 The role of energy metabolism in the regulation of energy balanceCharmaine S. Tam & Eric Ravussin.33 Treatment of obesity: lifestyle and pharmacotherapyArne Astrup.34 Treatment of obesity: bariatric surgery Karl J. Neff, Ele Ferrannini & Carel W. le Roux.35 Animal models of obesity and type 2 diabetes David A. York, Mie Jung Park–York & Timothy Gilbertson.36 The role of the hypothalamus in the maintenance of energy balance and peripheral glucose controlLuis Varela & Tamas L. Horvath.SECTION 7: CLINICAL TRIAL EVIDENCE IN DIABETES.37 Prevention of type 1 diabetesJay S. Skyler.38 Prevention of type 2 diabetesThomas Yates & Melanie Davies.39 Prevention of diabetic microvascular complicationsAlice P.S. Kong, Nicola Brown & Juliana C.N. Chan. .VOLUME 2.SECTION 8: MANAGEMENT OF DIABETES: DIET, EXERCISE AND DRUGS.40 Dietary management of diabetes mellitus in Europe and North America Jim I. Mann & Alexandra Chisholm.41 Exercise Henrik Galbo & Erik A. Richter.42 Sulfonylureas and meglitinides: insights into physiology and translational clinical utilityHarold E. Lebovitz & Arne Melander.43 Metformin and other biguanides: pharmacology and therapeutic usageSusan L. Samson & Alan J. Garber.44 PPAR agonists in the treatment of diabetes Sunder Mudaliar & Robert R. Henry.45 –Glucosidase inhibitorsJosée Leroux–Stewart, Rémi Rabasa–Lhoret & Jean–Louis Chiasson.46 Combination therapy in type 2 diabetes mellitusMuhammad Abdul–Ghani, Ralph A. DeFronzo & R. Eldor.47 New drugs for the treatment of diabetes mellitusClifford J. Bailey.48 Incretin–based therapies Michael A. Nauck & Juris J. Meier.49 Insulin pumps Dace L. Trence & Irl B. Hirsch.50 Innovative therapies in diabetes: colesevelam and bromocriptineShamsa Ali & Vivian Fonseca.SECTION 9: MANAGEMENT OF DIABETES: MONITORING AND OTHER INTERVENTIONS.51 Implantable pumps and artificial and bio–artificial pancreas systemWilliam Tamborlane & Miladys M. Palau–Collazo.52 Pancreas and islet transplantationR. Paul Robertson.53 Hypoglycemia and other complications of insulin therapy Stephanie A. Amiel.54 Diabetic ketoacidosis and hyperosmolar state Abbas E. Kitabchi, Guillermo E. Umpierrez & Mary Beth Murphy.SECTION 10: MANAGEMENT OF DIABETES: GLUCOSE AND LIPID MONITORING, SPECIFIC SUBGROUPS.55 Type 2 diabetes in obese adolescents: pathophysiology and treatmentGrace Kim & Sonia Caprio.56 Diabetes in pregnancy Yoel Toledano, Eran Hadar & Moshe Hod.57 Aging and diabetes mellitusHermes Florez, Jorge Ruiz & Medha Munshi.58 Psychological problems and management of patients with diabetes mellitusAlan M. Delamater, Ashley Marchante & Jennifer Hernandez.59 Glycated hemoglobin, serum proteins, and other markers as tools for monitoringSusan M. Gerber, Douglas Stickle, Intekhab Ahmed & Serge Jabbour.SECTION 11: COMPLICATIONS OF DIABETES: GENERAL AND MICROVASULAR.60 Pathogenesis of diabetic microvascular complicationsJosephine M. Forbes & Brooke Harcourt.61 Diabetic retinopathy and other ocular complicationsGavin S. Tan & Tien Yin Wong.62 Diabetic nephropathy George Jerums, Elif I. Ekinci, Erosha Premaratne, Scott T. Baker, Sianna Panagiotopoulos & Richard J. MacIsaac.63 Pathology of human diabetic neuropathyM. Mojaddidi, A.K. Sharma & Ravaz A. Malik.64 Autonomic neuropathy Chinmay S. Marathe, Liza Phillips & Michael Horowitz.65 Connective tissue disorders in diabetesArlan L. Rosenbloom.66 The diabetic foot Frank L. Bowling & Andrew J.M. Boulton.67 Erectile dysfunction in diabetes mellitusMichael H. Cummings & Rajesh Rajendran.68 Periodontal disease and diabetes mellitusWenche S. Borgnakke & Robert J. Genco.SECTION 12: COMPLICATIONS OF DIABETES: MACROVASCULAR.69 Epidemiology of macrovascular disease and hypertension in diabetes mellitusJaakko Tuomilehto, Daiva Rastenyte, Qing Qiao & Dimitrije Jakovljevic.70 Atherogenesis, coronary heart disease and insulin resistance syndrome in diabetes Barak Zafrir & Jorge Plutzky.71 Endothelial function and metabolic syndromeXinpu Chen & Sridevi Devaraj.72 Haemostatic abnormalities in diabetes mellitusR.A. Ajjan & Peter J. Grant.73 Clinical features and treatment of coronary heart disease in diabetesEberhard Standl, Michael Erbach, Markolf Hanefeld, Oliver Schnell, Bernd Stratmann & Diethelm Tschoepe.74 Arterial hypertension in diabetes: etiology and treatmentColleen Flynn & George Bakris.75 Peripheral vascular and cerebrovascular disease in diabetes mellitusDebabrata Mukherjee.SECTION 13: DIABETES AND PUBLIC HEALTH.76 The diabetes challenge: from human and social rights to the empowerment of people with diabetesC.T. Di Iorio, Fabrizio Carinci & M. Massi Benedetti.77 The economics of diabetes care: a global perspectiveRhys Williams.Index

• ISBN: 978-0-470-65861-1
• Editorial: Wiley–Blackwell
• Encuadernacion: Cartoné
• Páginas: 1328
• Fecha Publicación: 20/03/2015
• Nº Volúmenes: 1
• Idioma: Inglés